Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Increases 12.62% This Week; Should You Buy?

Tuesday, January 04, 2022 10:45 AM | InvestorsObserver Analysts

Mentioned in this article

Titan Pharmaceuticals, Inc. common stock (TTNP) Stock Increases 12.62% This Week; Should You Buy?

Titan Pharmaceuticals, Inc. common stock (TTNP) stock is down -64.09% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives TTNP stock a score of 30 out of a possible 100. That rank is influenced by a long-term technical score of 1. TTNP's rank also includes a short-term technical score of 13. The fundamental score for TTNP is 77. In addition to the average rating from Wall Street analysts, TTNP stock has a mean target price of $7.00. This means analysts expect the stock to increase 503.45% over the next 12 months.

TTNP has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on TTNP!

See Full TTNP Report

What's Happening with TTNP Stock Today

Titan Pharmaceuticals, Inc. common stock (TTNP) stock has gained 3.12% while the S&P 500 has risen 0.28% as of 10:44 AM on Tuesday, Jan 4. TTNP has risen $0.03 from the previous closing price of $1.12 on volume of 625,377 shares. Over the past year the S&P 500 is higher by 29.97% while TTNP is down -64.09%. TTNP lost -$0.48 per share in the over the last 12 months. Click Here to get the full Stock Report for Titan Pharmaceuticals, Inc. common stock stock.